2IA.F · iAnthus Capital Holdings, Inc

-

Please sign in to comment on 2IA.F

1 Comment

Admin

4 years, 1 month ago

iAnthus Capital Holdings, Inc is currently in a long term downtrend where the price is trading 23.9% below its 200 day moving average.

From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.3.

iAnthus Capital Holdings, Inc's total revenue rose by 49.2% to $41M since the same quarter in the previous year.

Its net income has increased by 96.2% to $-10M since the same quarter in the previous year.

Finally, its free cash flow grew by 69.5% to $-7M since the same quarter in the previous year.

Based on the above factors, iAnthus Capital Holdings, Inc gets an overall score of 4/5.

Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic
ISIN	CA45074T1021
Exchange	F
CurrencyCode	EUR

Market Cap	22M
PE Ratio	0.0
Target Price	0.05
Beta	0.85
Dividend Yield	None

ABOUT

iAnthus Capital Holdings, Inc

iAnthus Capital Holdings, Inc. owns and operates licensed cannabis cultivation, processing, and dispensary facilities in the United States. The company also develops, produces, and distributors of branded cannabis products. It offers cannabis flower and trims, such as packaged flowers and pre-rolls; cannabis infused products, including topical creams and edibles; vape cartridges, concentrates, live resins, wax products, oils, and tinctures. The company was formerly known as Ianthus Capital Management LLC and changed its name to iAnthus Capital Holdings, Inc. in August 2016. iAnthus Capital Holdings, Inc. was founded in 2014 and is headquartered in Toronto, Canada.

2IA.F · iAnthus Capital Holdings, Inc

-

iAnthus Capital Holdings, Inc

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest iAnthus Capital Holdings, Inc using a moving average strategy